Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 2
2019 1
2020 4
2021 5
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.
Mishima K, Nishikawa R, Narita Y, Mizusawa J, Sumi M, Koga T, Sasaki N, Kinoshita M, Nagane M, Arakawa Y, Yoshimoto K, Shibahara I, Shinojima N, Asano K, Tsurubuchi T, Sasaki H, Asai A, Sasayama T, Momii Y, Sasaki A, Nakamura S, Kojima M, Tamaru JI, Tsuchiya K, Gomyo M, Abe K, Natsumeda M, Yamasaki F, Katayama H, Fukuda H. Mishima K, et al. Among authors: sasaki n. Neuro Oncol. 2023 Apr 6;25(4):687-698. doi: 10.1093/neuonc/noac246. Neuro Oncol. 2023. PMID: 36334050 Free PMC article. Clinical Trial.
[Primary Central Nervous System Lymphoma].
Sasaki N. Sasaki N. No Shinkei Geka. 2023 Sep;51(5):901-909. doi: 10.11477/mf.1436204832. No Shinkei Geka. 2023. PMID: 37743342 Japanese.
Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death.
Yamamoto Y, Sasaki N, Kumagai K, Takeuchi S, Toyooka T, Otani N, Wada K, Narita Y, Ichimura K, Namba H, Mori K, Tomiyama A. Yamamoto Y, et al. Among authors: sasaki n. Neurol Med Chir (Tokyo). 2018 Jul 15;58(7):296-302. doi: 10.2176/nmc.ra.2018-0040. Epub 2018 Jun 13. Neurol Med Chir (Tokyo). 2018. PMID: 29899179 Free PMC article. Review.
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma.
Tateishi K, Miyake Y, Kawazu M, Sasaki N, Nakamura T, Sasame J, Yoshii Y, Ueno T, Miyake A, Watanabe J, Matsushita Y, Shiba N, Udaka N, Ohki K, Fink AL, Tummala SS, Natsumeda M, Ikegaya N, Nishi M, Ohtake M, Miyazaki R, Suenaga J, Murata H, Aoki I, Miller JJ, Fujii Y, Ryo A, Yamanaka S, Mano H, Cahill DP, Wakimoto H, Chi AS, Batchelor TT, Nagane M, Ichimura K, Yamamoto T. Tateishi K, et al. Among authors: sasaki n. Cancer Res. 2020 Dec 1;80(23):5330-5343. doi: 10.1158/0008-5472.CAN-20-2425. Epub 2020 Oct 16. Cancer Res. 2020. PMID: 33067267
The role of nonlinear dimension reduction of genome-wide DNA methylome in integrated diagnosis: A case study of glioblastoma, IDH-wildtype.
Satomi K, Saito K, Shimoyamada H, Onizuka H, Shibayama T, Hibiya T, Hayashi A, Nagahama K, Yamagishi Y, Sasaki N, Kobayashi K, Gomyo M, Nagane M, Shibahara J. Satomi K, et al. Among authors: sasaki n. Pathol Int. 2023 Oct;73(10):523-526. doi: 10.1111/pin.13359. Epub 2023 Aug 2. Pathol Int. 2023. PMID: 37530489 No abstract available.
Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance.
Yamamuro S, Takahashi M, Satomi K, Sasaki N, Kobayashi T, Uchida E, Kawauchi D, Nakano T, Fujii T, Narita Y, Kondo A, Wada K, Yoshino A, Ichimura K, Tomiyama A. Yamamuro S, et al. Among authors: sasaki n. Cancer Sci. 2021 Nov;112(11):4736-4747. doi: 10.1111/cas.15141. Epub 2021 Oct 2. Cancer Sci. 2021. PMID: 34536314 Free PMC article.
Black hairy tongue after chemotherapy for malignant brain tumors.
Yamagishi Y, Maruyama K, Kobayashi K, Kume S, Sasaki N, Yokoya S, Saito K, Shiokawa Y, Nagane M. Yamagishi Y, et al. Among authors: sasaki n. Acta Neurochir (Wien). 2017 Jan;159(1):169-172. doi: 10.1007/s00701-016-3036-5. Epub 2016 Nov 23. Acta Neurochir (Wien). 2017. PMID: 27878617
Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation.
Kobayashi T, Miyazaki M, Sasaki N, Yamamuro S, Uchida E, Kawauchi D, Takahashi M, Otsuka Y, Kumagai K, Takeuchi S, Toyooka T, Otani N, Wada K, Narita Y, Yamaguchi H, Muragaki Y, Kawamata T, Mori K, Ichimura K, Tomiyama A. Kobayashi T, et al. Among authors: sasaki n. Cancers (Basel). 2020 Dec 4;12(12):3641. doi: 10.3390/cancers12123641. Cancers (Basel). 2020. PMID: 33291680 Free PMC article.
17 results